SEGMENT INFORMATION (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT REVENUE

	Three months ended June 30,						Six months ended June 30,
	2025			2024			2025			2024
Revenues		1,778			1,739			3,307			3,250
Cost of Revenues:
Material and Labor		1,138			1,192			2,163			2,164
Other cost of revenues		327			216			539			463
Total Cost of Revenues		1,465			1,408			2,702			2,627
Research and development (R&D)
Payroll and Benefits		1,120			668			1,974			1,351
Share based compensation		645			682			1,314			1,151
Clinical trials		1,125			1,166			2,287			1,949
Other R&D		944			885			2,318			1,575
Total Research and development		3,834			3,401			7,893			6,026
Selling and marketing (S&M)
Payroll and Benefits		2,779			793			4,757			1,615
Share based compensation		595			264			812			514
Other S&M		798			388			1,353			553
Total Selling and marketing		4,172			1,445			6,922			2,682
General and administrative (G&A)
Payroll and Benefits		1,729			818			3,309			1,648
Share based compensation		1,920			1,726			3,700			3,510
Other G&A		1,677			1,201			3,260			2,431
Total General and administrative		5,326			3,745			10,269			7,589
Financial Income (expenses), net;		(132	)		351			162			733
Segment net Loss		(13,151	)		(7,909	)		(24,317	)		(14,941	)